BNP/CALL/STRYKER CORP./350/0.1/20.12.24 Share Price

Warrant

DE000PN38H47

Delayed Deutsche Boerse AG 04:20:43 28/06/2024 pm IST
1.95 EUR +0.52% Intraday chart for BNP/CALL/STRYKER CORP./350/0.1/20.12.24
Current month-5.37%
1 month-1.52%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
28/24/28 1.95 +0.52%
27/24/27 1.94 -1.52%
26/24/26 1.97 +6.49%
25/24/25 1.85 -4.64%
24/24/24 1.94 -8.49%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 04:20 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN38H4
ISINDE000PN38H47
Date issued 02/06/2023
Strike 350 $
Maturity 20/12/2024 (176 Days)
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.05
Lowest since issue 0.66
Spread 0.05
Spread %2.49%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.5 USD
Average target price
372.9 USD
Spread / Average Target
+9.51%
Consensus